270 related articles for article (PubMed ID: 20501935)
1. Controlling the fate of NIK: a central stage in noncanonical NF-kappaB signaling.
Sun SC
Sci Signal; 2010 May; 3(123):pe18. PubMed ID: 20501935
[TBL] [Abstract][Full Text] [Related]
2. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
[TBL] [Abstract][Full Text] [Related]
3. Non-canonical NF-κB signaling pathway.
Sun SC
Cell Res; 2011 Jan; 21(1):71-85. PubMed ID: 21173796
[TBL] [Abstract][Full Text] [Related]
4. Noncanonical NF-κB signaling is limited by classical NF-κB activity.
Gray CM; Remouchamps C; McCorkell KA; Solt LA; Dejardin E; Orange JS; May MJ
Sci Signal; 2014 Feb; 7(311):ra13. PubMed ID: 24497610
[TBL] [Abstract][Full Text] [Related]
5. Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosis.
Gray CM; McCorkell KA; Chunduru SK; McKinlay MA; May MJ
Biochem Biophys Res Commun; 2014 Jul; 450(1):341-6. PubMed ID: 24942881
[TBL] [Abstract][Full Text] [Related]
6. The noncanonical NF-κB pathway.
Sun SC
Immunol Rev; 2012 Mar; 246(1):125-40. PubMed ID: 22435551
[TBL] [Abstract][Full Text] [Related]
7. A Kinase Assay for Measuring the Activity of the NIK-IKK1 Complex Induced via the Noncanonical NF-κB Pathway.
Mukherjee T; Ratra Y; Banoth B; Deka A; Polley S; Basak S
Methods Mol Biol; 2021; 2366():165-181. PubMed ID: 34236638
[TBL] [Abstract][Full Text] [Related]
8. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
Matsushima A; Kaisho T; Rennert PD; Nakano H; Kurosawa K; Uchida D; Takeda K; Akira S; Matsumoto M
J Exp Med; 2001 Mar; 193(5):631-6. PubMed ID: 11238593
[TBL] [Abstract][Full Text] [Related]
9. B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation.
Bhattacharyya S; Borthakur A; Tyagi S; Gill R; Chen ML; Dudeja PK; Tobacman JK
J Biol Chem; 2010 Jan; 285(1):522-30. PubMed ID: 19897484
[TBL] [Abstract][Full Text] [Related]
10. Molecular determinants of NF-kappaB-inducing kinase action.
Lin X; Mu Y; Cunningham ET; Marcu KB; Geleziunas R; Greene WC
Mol Cell Biol; 1998 Oct; 18(10):5899-907. PubMed ID: 9742107
[TBL] [Abstract][Full Text] [Related]
11. Expanding the Interactome of the Noncanonical NF-κB Signaling Pathway.
Willmann KL; Sacco R; Martins R; Garncarz W; Krolo A; Knapp S; Bennett KL; Boztug K
J Proteome Res; 2016 Sep; 15(9):2900-2909. PubMed ID: 27416764
[TBL] [Abstract][Full Text] [Related]
12. Maximal adamantyl-substituted retinoid-related molecule-induced apoptosis requires NF-κB noncanonical and canonical pathway activation.
Farhana L; Dawson MI; Murshed F; Fontana JA
Cell Death Differ; 2011 Jan; 18(1):164-73. PubMed ID: 20671747
[TBL] [Abstract][Full Text] [Related]
13. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.
Yang CH; Murti A; Pfeffer LM
J Biol Chem; 2005 Sep; 280(36):31530-6. PubMed ID: 16009713
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.
Liao G; Zhang M; Harhaj EW; Sun SC
J Biol Chem; 2004 Jun; 279(25):26243-50. PubMed ID: 15084608
[TBL] [Abstract][Full Text] [Related]
15. Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation.
Rosebeck S; Madden L; Jin X; Gu S; Apel IJ; Appert A; Hamoudi RA; Noels H; Sagaert X; Van Loo P; Baens M; Du MQ; Lucas PC; McAllister-Lucas LM
Science; 2011 Jan; 331(6016):468-72. PubMed ID: 21273489
[TBL] [Abstract][Full Text] [Related]
16. The RET/PTC3 oncogene activates classical NF-κB by stabilizing NIK.
Neely RJ; Brose MS; Gray CM; McCorkell KA; Leibowitz JM; Ma C; Rothstein JL; May MJ
Oncogene; 2011 Jan; 30(1):87-96. PubMed ID: 20818435
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
Cherry EM; Lee DW; Jung JU; Sitcheran R
Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO
Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002
[TBL] [Abstract][Full Text] [Related]
20. NIK and IKKbeta interdependence in NF-kappaB signalling--flux analysis of regulation through metabolites.
Kim HB; Evans I; Smallwood R; Holcombe M; Qwarnstrom EE
Biosystems; 2010 Feb; 99(2):140-9. PubMed ID: 19909783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
